A detailed history of Telemetry Investments, L.L.C. transactions in Mustang Bio, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 392,700 shares of MBIO stock, worth $113,882. This represents 0.24% of its overall portfolio holdings.

Number of Shares
392,700
Previous 452,500 13.22%
Holding current value
$113,882
Previous $212,000 26.89%
% of portfolio
0.24%
Previous 0.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.32 - $8.27 $19,136 - $494,546
-59,800 Reduced 13.22%
392,700 $155,000
Q3 2022

Nov 17, 2022

BUY
$0.46 - $7.2 $8,050 - $126,000
17,500 Added 4.02%
452,500 $212,000
Q2 2022

Aug 15, 2022

BUY
$0.58 - $1.13 $79,750 - $155,374
137,500 Added 46.22%
435,000 $254,000
Q1 2022

May 16, 2022

BUY
$0.73 - $1.81 $93,075 - $230,775
127,500 Added 75.0%
297,500 $300,000
Q4 2021

Feb 14, 2022

BUY
$1.66 - $2.64 $74,700 - $118,800
45,000 Added 36.0%
170,000 $282,000
Q3 2021

Nov 15, 2021

BUY
$2.58 - $3.36 $322,500 - $420,000
125,000 New
125,000 $336,000
Q1 2021

May 17, 2021

SELL
$3.02 - $5.16 $449,980 - $768,840
-149,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$2.66 - $4.18 $200,010 - $314,302
-75,192 Reduced 33.54%
149,000 $564,000
Q3 2020

Nov 16, 2020

SELL
$3.01 - $3.88 $15,049 - $19,400
-5,000 Reduced 2.18%
224,192 $706,000
Q2 2020

Aug 14, 2020

BUY
$2.33 - $4.6 $401,931 - $793,513
172,503 Added 304.3%
229,192 $729,000
Q1 2020

May 15, 2020

BUY
$1.91 - $4.52 $108,275 - $256,234
56,689 New
56,689 $152,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $30.5M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.